Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

NOC

Northrop Grumman Investor Overview – Key Points for Executives

Shares of Industrials sector company Northrop Grumman moved 9.7% today, and are now trading at a price of $565.51. The Large-Cap stock's daily volume was 1,832,978 compared to its average volume of 914,168. The S&P 500 index returned a 0.0% performance.

Northrop Grumman Corporation operates as an aerospace and defense technology company in the United States, the Asia/Pacific, Europe, and internationally. The company is based in Falls Church and has 97,000 full time employees. Its market capitalization is $81,392,033,792. Northrop Grumman currently offers its equity investors a dividend that yields 1.6% per year.

22 analysts are following Northrop Grumman and have set target prices ranging from $480.0 to $658.0 per share. On average, they have given the company a rating of buy. At today's prices, NOC is trading 2.23% away from its average analyst target price of $553.19 per share.

Over the last year, NOC's share price has increased by 16.5%, which represents a difference of 3.0% when compared to the S&P 500. The stock's 52 week high is $567.12 per share whereas its 52 week low is $426.24. Northrop Grumman's average free cash flow over the last 5 years has been $2.38 Billion, but they have been decreasing at an average rate of -2.4%. This may prove a challenge to the long term sustainability of the stock's upwards trend.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2024 4,388,000 1,767,000 2,621,000 24.81
2023 3,875,000 1,775,000 2,100,000 43.25
2022 2,901,000 1,435,000 1,466,000 -31.88
2021 3,567,000 1,415,000 2,152,000 -25.41
2020 4,305,000 1,420,000 2,885,000 -4.88
2019 4,297,000 1,264,000 3,033,000
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS